March 7, 2018 / 9:13 PM / 2 months ago

BRIEF-Protagonist Therapeutics Q4 Loss Per Share $0.15

March 7 (Reuters) - Protagonist Therapeutics Inc:

* PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS

* PROTAGONIST THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.15

* PROTAGONIST THERAPEUTICS - ANTICIPATE HAVING ENOUGH CASH, CASH EQUIVALENTS, INVESTMENTS TO SUPPORT OPERATIONS THROUGH 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below